Pentostatin
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
Molecular Identity
Pentostatin
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
PubChem CID: 439693
Pentostatin can cause developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C11H16N4O4
Molecular Formula
268.27
Molecular Weight
g/mol
268.1172
Exact Mass
Da
-2.1
XLogP
Drug-like (Lipinski: < 5)
112
TPSA
Good oral absorption (< 140 A²)
4
H-Bond Donors
6
H-Bond Acceptors
356
Complexity
SMILES
Canonical SMILES
SMILES: C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)OIsomeric SMILES
SMILES: C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)OSynonyms(20)
pentostatinDeoxycoformycin53910-25-1NipentPentostatinaPentostatineCI-825Pentostatinum2'-DCFCO-VidarabineYK-176NSC-218321PD 81565PD-81565DTXSID2023436
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pentostatin
Loading drug network...